Our Board of Directors

Annexon’s Board of Directors is comprised of accomplished leaders in biotechnology and investments, with expertise in corporate governance, research and development, commercialization, and finance.

William (Bill) Young

Board Chair
INDUSTRY EXECUTIVE & BOARD MEMBER

Douglas Love, Esq

PRESIDENT & CEO
ANNEXON

Campbell Murray, MD

Board Member
MANAGING DIRECTOR
NOVARTIS VENTURE FUND

Muneer Satter

Board Member
MANAGING PARTNER
SATTER INVESTMENT MANAGEMENT

Emmett Cunningham, MD, PhD, MPH

Board Member
PARTNER
BLACKSTONE (CLARUS VENTURES)

Carol Gallagher, PharmD

Board Member
PARTNER
NEW ENTERPRISE ASSOCIATES, INC.

Ricky Sun, PhD

Board Member
PARTNER
BAIN CAPITAL LIFE SCIENCES

Thomas G. Wiggans

Independent Board Member
FOUNDER & CEO
DERMIRA
Leadership Scientific Advisors Founders Investors